ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
42
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,529
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome.
Author(s):
J Boutin
,
Ryan A. LaCroix
,
P Hamet
Publication date:
1999-11-18
Journal:
The New England journal of medicine
Keywords:
Adrenocorticotropic Hormone
,
blood
,
Cushing Syndrome
,
drug therapy
,
metabolism
,
Female
,
Gonadotropin-Releasing Hormone
,
pharmacology
,
Humans
,
Hydrocortisone
,
secretion
,
Leuprolide
,
therapeutic use
,
Luteinizing Hormone
,
drug effects
,
Middle Aged
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Drug_transporters
Author and article information
Journal
PubMed ID::
10564687
DOI::
10.1056/NEJM199911183412104
ScienceOpen disciplines:
Chemistry
Keywords:
Adrenocorticotropic Hormone
,
blood
,
Cushing Syndrome
,
drug therapy
,
metabolism
,
Female
,
Gonadotropin-Releasing Hormone
,
pharmacology
,
Humans
,
Hydrocortisone
,
secretion
,
Leuprolide
,
therapeutic use
,
Luteinizing Hormone
,
drug effects
,
Middle Aged
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adrenocorticotropic Hormone
,
blood
,
Cushing Syndrome
,
drug therapy
,
metabolism
,
Female
,
Gonadotropin-Releasing Hormone
,
pharmacology
,
Humans
,
Hydrocortisone
,
secretion
,
Leuprolide
,
therapeutic use
,
Luteinizing Hormone
,
drug effects
,
Middle Aged
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,529
Structure of the lutein-binding domain of human StARD3 at 1.74 Å resolution and model of a complex with lutein
Authors:
Martin P. Horvath
,
Evan George
,
Quang T. Tran
…
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides
Authors:
Yingfu Li
,
Mikayo Kataoka
,
Miyuki Tatsuta
…
Lutein Enhances Bone Mass by Stimulating Bone Formation and Suppressing Bone Resorption in Growing Mice.
Authors:
Chisato Miyaura
,
Masaki Inada
,
Florian M W Grundler
…
See all similar
Cited by
42
Clinical review: Diagnosis and treatment of subclinical hypercortisolism.
Authors:
Iacopo Chiodini
At the Crossroads of Fate—Somatic Cell Lineage Specification in the Fetal Gonad
Authors:
Emmi Rotgers
,
Anne Jørgensen
,
Humphrey Hung-Chang Yao
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience
Authors:
N.M. Albiger
,
F Ceccato
,
M. Zilio
…
See all cited by